1. Home
  2. EAT vs IBRX Comparison

EAT vs IBRX Comparison

Compare EAT & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brinker International Inc.

EAT

Brinker International Inc.

HOLD

Current Price

$157.31

Market Cap

6.8B

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$6.99

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EAT
IBRX
Founded
1975
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.2B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
EAT
IBRX
Price
$157.31
$6.99
Analyst Decision
Buy
Strong Buy
Analyst Count
21
7
Target Price
$183.00
$12.57
AVG Volume (30 Days)
829.0K
12.9M
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
144.71
38.71
EPS
7.90
N/A
Revenue
$5,384,200,000.00
$113,288,000.00
Revenue This Year
$9.00
$88.59
Revenue Next Year
$5.49
$131.15
P/E Ratio
$19.47
N/A
Revenue Growth
21.95
668.31
52 Week Low
$100.30
$1.95
52 Week High
$187.12
$12.43

Technical Indicators

Market Signals
Indicator
EAT
IBRX
Relative Strength Index (RSI) 61.25 43.67
Support Level $128.82 $6.69
Resistance Level $166.12 $8.54
Average True Range (ATR) 7.43 0.39
MACD 1.92 -0.04
Stochastic Oscillator 84.04 29.74

Price Performance

Historical Comparison
EAT
IBRX

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: